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Background: Serum response factor (SRF) is a widely expressed transcription factor involved in multiple regulatory
programs. It is believed that SRF can toggle between disparate programs of gene expression through association
with different cofactors. However, the direct evidence as to how these factors function on a genome-wide level is
still lacking.
Results: In the present study, I explored the functions of SRF and its representative cofactors, megakaryoblastic
leukemia 1/2 (MKL1/2) and ETS-domain protein 4 (ELK4), during fungal infection challenge in macrophages. The
knockdown study, combined with gene expression array analysis, revealed that MKL1/2 regulated SRF-dependent
genes were related to actin cytoskeleton organization, while ELK4 regulated SRF-dependent genes were related to
external stimulus responses. Subsequent chromatin immunoprecipitation coupled with massively parallel sequencing
(ChIP-seq) suggested that many of these regulations were mediated directly in cis.
Conclusions: I conclude that SRF utilizes MKL1/2 to fulfill steady state cellular functions, including cytoskeletal
organization, and utilizes ELK4 to facilitate acute responses to external infection. Together, these findings indicate that SRF,
along with its two cofactors, are important players in both cellular homeostasis and stress responses in macrophages.
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Macrophages are an important subset of innate immune
cells implicated in host defense against bacterial and viral
infections. Three of their major functions include phago-
cytosis and degradation of foreign pathogens, clearance of
apoptotic or necrotic host cells, and rapid generation of
effector cytokines that orchestrate immune responses.
These different functions of macrophages are likely regu-
lated by distinct transcription programs.
Serum response factor (SRF) is a member of the MADS
(Mcm1, Agamous, Deficiens, SRF) transcription factor
family [1] and is abundantly expressed in a variety of cell
types. Deletion of Srf is embryonic lethal [2]. Conditional
deletion of Srf revealed its essential functions in manyCorrespondence: xielan@tsinghua.edu.cn
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unless otherwise stated.tissues, including skeletal, cardiac and smooth muscle cells
[3,4], neurons [5], and thymocytes [6,7]. At the cellular
level, these phenotypes can be attributed to impaired
expression of different sets of SRF target genes. SRF-
regulated immediate early genes (IEGs), such as c-fos,
early growth response 1 (Egr1) and junB, are important
for cell growth and proliferation [8-10], while SRF-
regulated troponin, vinculin (Vcl), and SM22α partici-
pate in muscle-specific contractile functions [9,11].
With high affinity and specificity, homodimeric SRF
binds to a consensus cis-element known as a CArG box,
with the sequence of CC(A/T)6GG [12,13]. SRF regulates
diverse programs of gene expression through its associ-
ation with different accessory factors. The most well-
studied cofactors of SRF include members of the ternary
complex factor (TCF) and myocardin families [9] of tran-
scription factors. The TCF family of proteins includes
ELK1, ELK3 (also known as SAP2, Net) and ELK4 (also
known as SAP1). TCFs respond to mitogen-activated pro-
tein kinase (MAPK) signaling initiated by serum or growthis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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TCFs interact with SRF and simultaneously bind to an
ETS binding site adjacent to the CArG box. Together, the
CArG box and the ETS site are recognized as the serum
response element (SRE) [15]. Myocardin family members
include myocardin, megakaryoblastic leukemia 1 (MKL1,
also known as MAL, MRTF-A and BSAC) and MKL2
(also known as MRTF-B). Myocardin is strictly expressed
in cardiac and smooth muscle cells, while MKL1 and 2
exhibit broader expression patterns [16]. MKLs connect
actin dynamics with SRF activation [17] and can regulate
muscle-specific contractile genes in response to actin
polymerization [18]. Unlike TCFs, MKL1 and MKL2 do
not bind DNA sequences directly [19]; instead, they associ-
ate with SRF to regulate the transcription of target genes.
SRF interaction with MKLs and TCFs is mutually exclusive
[20,21], but recently, MKLs were reported to regulate the
expressions of some IEGs in response to serum induction
[22,23]. However, little is known about how these two fam-
ilies coordinate with SRF on a genome-wide level.
Macrophages express a variety of toll-like receptors
(TLRs) on their cell surface that enable recognition of
molecules, known as pathogen-associated molecular pat-
terns (PAMPs) [24], that are broadly expressed by patho-
gens, but not by the host. Zymosan, a yeast cell wall
derivative, induces inflammatory responses in macro-
phages through binding to the dectin-1 receptor or TLR2/
6 heterodimers [25]. The function of SRF in macrophages
had not been investigated until our previous studies
revealed that SRF regulates both general and cell type-
restricted cytoskeletal gene expression programs in these
cells [26]. Interestingly, we also found that the SRF/MADS
(CArG box) motif is highly enriched in the promoters of
zymosan-induced genes and that SRF indirectly modulates
type I interferon signaling in macrophages [27]. Overall,
these studies suggest a possible role of SRF in the immune
responses of macrophages.
With recent advances in parallel high throughput se-
quencing, I sought to map out the genome-wide occu-
pancy of SRF and its cofactors, MKL1/2 and ELK4. In
this study, RNA interference was used to knock down
SRF, MKL1/2, and ELK4, followed by genome-wide ex-
pression profiling analysis and ChIP-seq experiments to
identify the target genes and direct binding sites of these
cofactors. Together, I demonstrate that the two SRF co-
factor families, TCFs and MKLs, regulate distinct subsets
of SRF target gene programs during fungal infection in
macrophages.
Results
SRF is required for macrophage responses to
zymosan treatment
In order to identify the transcription factors that are in-
volved in gene regulation in response to fungal infectionin macrophages, I stimulated primary macrophages with
zymosan for 1 h and harvested RNA for microarray ana-
lysis. Motif analysis on the promoters of genes shown by
the array to be induced by zymosan identified the SRF/
MADS (CArG box) motif as one of the most highly
enriched motifs [27] (Additional file 1: Figure S1A). This
is in accordance with the fact that SRF functions as an
immediate responder to external stimuli such as growth
factors or serum. Interestingly, Srf transcription was
increased 2-fold after 1 h of zymosan treatment, but
returned to baseline after 6 h of treatment (Additional
file 1: Figure S1B), suggesting that SRF activation is an
immediate early phase response. To evaluate if this
change in mRNA expression had a functional effect, I
transfected RAW264.7 cells with a reporter construct
containing 3 tandem SRF-binding cis-elements (3×CArG).
After 1 h of treatment with zymosan, I found an approxi-
mately three-fold increase in reporter activity (Additional
file 1: Figure S1C). Next, I evaluated the impact of knock-
ing down Srf in zymosan treated elicited mouse peritoneal
macrophages by using microarray analysis [27]. Consider-
ing that the transcription of Srf was induced quickly and
that the SRF motif was enriched in the early phase of
zymosan treatment, I decided to focus the rest of my
study on cells treated with ligand for short periods of time.
To identify SRF-dependent genes, I filtered the microarray
results to isolate the set of transcripts whose expressions
were reduced by more than 1.5 fold with SRF-specific
siRNA after 1 h of zymosan treatment. The resulting sub-
set contained 264 non-redundant downregulated genes
and 203 upregulated genes (full list in Additional file 2:
Table S1), which indicates that SRF can be induced by
zymosan stimulation and that it is an important contribu-
tor to macrophage responses to external stimuli.
To investigate which biological functions the SRF target
genes are involved in, I performed gene ontology (GO)
analysis of the SRF regulated genes using the DAVID
Functional Annotation Tool. The top 5 functional annota-
tions are shown in Figure 1A (full results in Additional
file 3: Table S2, Part I). The most significantly enriched
item was “actin cytoskeleton organization”, which is a
function of SRF that has been elucidated in other cell
types and in our previous study in quiescent macro-
phages [26]. It is noteworthy that some genes within this
subgroup , such as Coro1a [28], Lsp1 [29] and Lcp1 [30],
are preferentially expressed in cells that are of myeloid
or hematopoietic origin and regulate macrophage specific
functions such as phagocytosis or migration. Moreover,
other GO terms that are closely related to macrophage
specific functions were also significantly enriched such as
“regulation of cell adhesion” (including Cd24a, Cited2,
Csf1, Itga6, MMP14, Srf, Thbs1 and Tgm2) and “response
to external stimulus” (including Cd24a, Bat5, Hps1, MEFV,
Arg1, F13A1, C1QB, CFP, Coro1a, ENTPD1, GPR77, Igfbp4,
Figure 1 SRF is required for macrophage function in response to zymosan stimulation. (A) Gene ontology analysis for biological process
annotations of downregulated and upregulated SRF dependent genes after zymosan treatment for 1 h. (B) mRNA expression profiles of the
indicated representative SRF dependent genes were analyzed by Q-PCR. Thioglycollate-elicited macrophages were transfected with nonspecific
(NS) or specific siRNAs for SRF and treated with or without zymosan for 1 h. **p < 0.01 vs. NS; *p < 0.05 vs. NS. Target gene expression is
represented as the average fold change compared to NS siRNA transfected samples of at least three independent experiments. Error bars
represent standard deviations.
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and Il10).
I validated the expression changes of some representa-
tive target genes by quantitative PCR (Q-PCR). As ex-
pected, several groups of target genes were confirmed as
SRF dependent, including: (1) general actin cytoskeleton
related genes such as cofilin1 (Cfl1) and Vcl, and the mi-
gration related gene, lymphocyte-specific protein 1 (Lsp1);
(2) adhesion related genes like thrombospondin 1 (Thbs1);
(3) genes related to stimulus responses such as Il10 and
Egr3; and (4) genes related to other functions, including
fms-related tyrosine kinase 1 (Flt1) and fos-like antigen 2
(Fosl2) (Figure 1B). All of these results indicate that SRF is
required for intact expression of genes closely related to
macrophage functions.
GO analysis of the genes upregulated by SRF knockdown
under zymosan treated conditions resulted in the identifica-
tion of more generic terms such as “cellular process”,
“nucleosome assembly” and “regulation of metabolic process”
(Figure 1A, full results in Additional file 3: Table S2,
Part II). Besides regulating the transcription of target
genes, SRF is known to regulate some miRNAs [31-33]
associated with altered expression of mRNAs and pro-
teins. The genes upregulated upon SRF knockdown could
potentially be downstream targets of SRF through the
regulation of miRNAs. Using Ingenuity Pathway Analysis,I compiled a list of 10 overrepresented miRNAs for
the 203 upregulated genes, which included miR-16-5p,
miR-489, miR-205-5p, miR-101, miR-291a-3p, miR-204-
5p, miR-33, miR-615-3p, miR-424-3p and miR-10a-5p.
Although there is no current literature linking any of
these miRNAs to SRF, it would be interesting to test, in
future studies, whether these miRNAs are actually novel
targets of SRF.
MKL1/2 and ELK4 regulate different subsets of genes in
zymosan treated macrophages
Previous studies of SRF in muscle cells suggested that SRF
participates in different regulatory programs by associat-
ing with different transcription cofactors. This mechanism
enables SRF to toggle between regulating cell proliferation
and growth and orchestrating actin cytoskeletal and con-
tractile homeostasis. I next sought to investigate accessary
factors utilized for SRF function in response to zymosan
stimulation in macrophages. I focused on two well-known
SRF associated cofactor families: the myocardin and TCF
families of transcription cofactors.
MKL1 and MKL2, share many redundant functions [23]
and are both highly expressed in primary macrophages.
Unlike Srf, mRNA levels of Mkl1 and Mkl2 stay constant
after zymosan treatment (Additional file 4: Figure S2A).
Because of their many redundancies, I used an siRNA
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expressions simultaneously to better assess their role in
macrophages (Additional file 4: Figure S2A, MKL1/2 will
denote both MKL1 and MKL2 in the following text). Elk4
is the dominantly expressed member of the TCF family
in primary macrophages (Additional file 4: Figure S2B).
Similar to Mkl1/2, Elk4 expression does not change dur-
ing zymosan treatment (Additional file 4: Figure S2B).
Transfection of macrophages with Elk4-specific siRNAs
significantly reduced Elk4 expression compared with
control siRNA transfected samples (Additional file 4:
Figure S2C). I also confirmed that the knockdown effect
is specific for Elk4 and that mRNA expression for Elk1
and Elk3 were unaffected (Additional file 4: Figure S2C).
Following confirmation of the siRNA knockdown effi-
ciencies, I performed gene expression array analysis on
my samples to compare the gene expression changes in
Mkl1/2 and Elk4 knockdown cells versus control siRNA
transfected cells after zymosan treatment for 1 h.
Using 1.5 fold reduction as a cutoff, I identified a total
of 309 genes that were MKL1/2 dependent (full list in
Additional file 5: Table S3) and 265 genes that were ELK4
dependent (full list in Additional file 6: Table S4). TheseFigure 2 MKL1/2 and ELK4 regulate the transcription of different gen
indicating the relationships between SRF dependent genes with respect to
biological process annotations of the SRF dependent or independent MKL1
analysis for biological process annotations of the SRF dependent or indeperesults indicate that the absence of these cofactors would
have an impact on zymosan induced gene expression in
macrophages.
To check if MKL1/2 contributes to SRF related functions
in macrophages, I compared the 309 MKL1/2 target genes
with the 264 SRF target genes. This analysis identified 60
MKL1/2 target genes that were also dependent on SRF for
their expression (Figure 2A). GO analysis of these 60 genes
identified the term of “actin cytoskeleton organization” as
the top hit. When I performed GO analysis on the MKL1/2
target genes that were independent of SRF expression, I
found that “positive regulation of biological process” ranked
as the first significant term (Figure 2B). Taken together,
these results suggest that MKL1/2 could coordinate with
SRF to regulate cytoskeleton related target genes, but may
also have other generic functions independent of SRF.
By comparing the 265 ELK4 target genes with the 264
SRF target genes, I identified 24 genes that were dependent
on both ELK4 and SRF for their expression (Figure 2A).
GO analysis of these 24 genes identified two significantly
enriched terms: “response to external stimulus” and “regu-
lation of transcription from RNA polymerase II promoter”.
This result indicates that ELK4 is involved in a differente sets in zymosan induced macrophages. (A) Venn diagram
MKL1/2 and ELK4 dependence. (B) Gene ontology analysis for
/2 target genes after zymosan treatment for 1 h. (C) Gene ontology
ndent ELK4 target genes after zymosan treatment for 1 h.
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dependent genes are enriched for the GO term related to
stress responses in gene ontology analysis is consistent with
our finding that besides the SRF motif, the ELK4 motif is
also highly enriched in the promoters of zymosan-induced
genes in primary macrophages (Additional file 1: Figure
S1A). Since the majority of ELK4 dependent target genes
are not dependent on SRF for expression, ELK4 may have
some SRF independent functions in macrophages. Simi-
lar GO analysis on the SRF independent ELK4 target
genes showed the term “cellular process” shifted to the
top, followed by “response to stress” and “cell division”,
etc. (Figure 2C).
Taken together, these findings support the view that
MKL1/2 and ELK4 are involved in distinct functions of
SRF in zymosan treated macrophages. Specifically, MKL1/2
is involved in actin cytoskeleton organization, ELK4 con-
tributes to establishing responses to external stresses, and
both sides constitute important functions of SRF in macro-
phages. Moreover, I found that both MKL1/2 and ELK4Figure 3 Expression profiles of MKL1/2 and ELK4 dependent target gene
MKL1/2 dependent genes (Cfl1, Dstn, Vcl and Thbs1) and ELK4 dependent gene
macrophages were transfected with NS or specific siRNAs for MKL1/2 or ELK4, a
expression in response to MKL1/2 or ELK4 knockdown under basal conditions o
represented as the average fold change compared to NS siRNA transfected sam
Error bars represent standard deviations.have roles that are independent of SRF and that they may
perform these roles independently or in coordination with
other transcription factors. Additional work will be ne-
cessary to explore how SRF and these cofactors work on
the genome directly and also to identify other potential
cofactors.
MKL1/2 and ELK4 dependent target genes show different
responses to zymosan induction
Similar to the SRF target genes, I also validated repre-
sentative target genes of MKL1/2 and ELK4 by Q-PCR. I
verified the MKL1/2 dependence of a subset of genes
with functional annotations linked to actin cytoskeleton
organization, including Cfl1, Dstn,Vcl, and Thbs1. All four
of these genes are highly expressed in macrophages in the
basal state. While the former two genes were not regu-
lated by zymosan, the latter two were slightly upregulated
by zymosan treatment. Expression of all 4 genes was re-
duced 30-60% by MKL1/2 knockdown (Figure 3A). More-
over, ELK4 expression was not required for the expressions in response to zymosan treatment. (A) and (B) Expressions of
s (Il10, c-fos, Egr1 and Egr3) were analyzed by Q-PCR. Thioglycollate-elicited
s indicated, and treated with or without zymosan for 1 h. (C) Srf mRNA
r after treatment with zymosan for 1 h. Target gene expression is
ples of three independent experiments. **p < 0.01 vs. NS; *p < 0.05 vs. NS.
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Vcl and Cnn2 (Additional file 4: Figure S2D).
I also verified the ELK4 dependence of a subset of stimu-
lus response genes, including Egr1, c-fos, Il10, and Egr3
(Figure 3B). The expression of these four genes can be in-
duced as much as 100 fold by zymosan, in contrast to actin
related genes. Although not revealed by microarray evalu-
ation, I found by Q-PCR that knocking down MKL1/2 also
impaired the expression of some stimulus response genes
such as Egr3 and Il10 (Additional file 4: Figure S2E).
Generation of a BLRP-MKL1-BirA stable cell line for
ChIP-seq analysis in RAW264.7 macrophages
While knockdown experiments combined with mRNA
expression analysis helped to identify the genes whose
expressions are dependent on SRF, MKL1/2 and ELK4, it
could not tell me whether these dependencies are through
direct transcriptional regulation or through a secondary
effect. It has been reported (and our expression data con-
firms) that SRF regulates the expression of itself [34,35]
and that this effect is dependent on both MKL and TCF
cofactors [14,18,36]. Thus, it is possible that knocking
down MKL1/2 and ELK4 could cause reduced expressions
of some target genes through reducing the expression of
Srf. As shown in Figure 3C, knocking down MKL1/2
reduced the expression of Srf more than 50%, under
both basal and zymosan treated conditions (p < 0.001 and
p = 0.017, respectively). Knocking down ELK4 showed a
similar effect (p = 0.036 and 0.013, respectively). This re-
sult is consistent with previous reports that there is an
MKL and TCF-dependent positive feedback loop for
SRF-dependent autoregulation [14,18,36].
To identify the direct targets of SRF and its cofactors on
a genome-wide level, I performed ChIP followed by high
throughput sequencing of the enriched DNA fragments
(ChIP-seq). MKL1 and MKL2 do not bind DNA sequences
directly [19]; instead, they associate with SRF to regulate
the transcription of target genes. As the binding affinity of
MKL1/2 to the DNA fragment is relatively weak, conven-
tional ChIP assay with MKL1 antibody failed to provide
sufficient enrichment on known target genes in macro-
phages (data not shown). To this end, I generated a BLRP-
tagged MKL1 expression vector and transfected it into
RAW264.7 cells to generate a stable cell line exoge-
nously expressing BLRP-MKL1 (BLRP-MKL1-BirA
stable cell line). A TEV-based ChIP strategy was then
performed for MKL1 using this stable cell line, followed
by sequencing analysis. I note here that SRF and ELK4
directly bind DNA, so ChIP-seq using commercial anti-
bodies against endogenous proteins were possible in the
MKL1 overexpressed BirA stable cell line.
Stable clones with highly expressed BLRP-MKL1 were
identified and selected by RT-qPCR with primers targeting
the BLRP sequence (Additional file 7: Figure S3A). Blrpexpression was approximately 4000 times higher in the
stable cell line compared to parental BirA cells and the
Blrp mRNA can be further induced as much as 10 fold
following 1 h of zymosan treatment. MKL1 expression
levels in this stable clone were twice as high as in the BirA
parental cell line under basal conditions and were in-
duced 7.5 fold after 1 h of zymosan treatment (Additional
file 7: Figure S3A). The high expression of MKL1 protein
was also confirmed by western blot (Additional file 7:
Figure S3B).
Global localization of SRF, MKL1 and ELK4 in macrophages
All the ChIP-seq assays were performed in zymosan treated
BLRP-MKL1-BirA stable cells. Using a false discovery rate
of 0.1%, I identified a total of 5025 SRF-specific peaks, 1140
MKL1-specific peaks and 783 ELK4-specific peaks (Full
lists are provided in Additional file 8: Table S5, Additional
file 9: Table S6 and Additional file 10: Table S7, respec-
tively). Each of these peaks were then annotated to the clo-
sest RefSeq gene observed. Among the 5025 SRF-bound
peaks, I found 781 and 350 peaks that were also associated
with MKL1 and ELK4 binding, respectively. Furthermore,
104 SRF peaks were associated with both MKL1 and ELK4
(Figure 4A). There were also a number of SRF associated
peaks that did not overlap with MKL1 and ELK4 binding
sites, indicating that there may be other cofactors utilized
by SRF. For MKL1, the majority of the peaks (68.5%, 781
out of 1140) were associated with SRF. However, the per-
centage for ELK4 association with SRF peaks was relatively
lower (44.7%, 350 out of 783), indicating that ELK4 may
have other functions independent of SRF and could have
other co-regulators [37].
Motif analysis of the 5025 nearest genes associated
with SRF peaks by oPOSSUM recovered many tran-
scription factor binding sites (TFBSs). As expected, SRF
and ELK4 were among the top hits, together with GABPA,
NFκB, Staf, TEAD1, NFYA, RELA, CREB1, STAT1 and
RREB1 (Figure 4B). Some of the overrepresented TFs have
been reported as cofactors of SRF already, including NFκB,
TEAD1, NFYA and RELA [38-42]. My study also revealed
additional potential cofactors of SRF, such as GABPA,
Staf, CREB1, STAT1 and RREB1. The most highly en-
riched motif for MKL1 bound genes was SRF, followed by
MEF2A, NFκB, STAT1, IRF1, MIZF, FOXF2, GABPA,
NFYA, RELA and CREB1 (Figure 4B). Most of the over-
represented TFBSs of MKL1 peaks coincided with those
of SRF (including NFκB, STAT1, GABPA, NFYA, RELA
and CREB1), suggesting that MKL1 might be involved in
the same complex with SRF and other cofactors. However,
there is also the possibility that MKL1 might interact with
the novel cofactors, independently of SRF, to regulate spe-
cific target genes.
For ELK4 bound genes, ELK4 and SRF motifs were
significantly enriched, together with NFYA and GABPA
Figure 4 Genomic analysis of SRF, MKL1 and ELK4 ChIP-seq peaks in macrophages. (A) Venn diagram of the overlap between SRF, MKL1,
and ELK4 peaks identified by ChIP-seq experiments in BLRP-MKL1-BirA stable cells. (B) Motif enrichment analysis of all significant SRF, MKL1 and
ELK4 bound genes. (C) Genomic location annotation analysis of significant SRF, MKL1 and ELK4 ChIP-seq peaks, as indicated (>20 tag counts).
(D) The percentage of ncRNAs associated with SRF bound intergenic peaks. (E) The classification of ncRNAs associated with SRF bound
intergenic peaks.
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both ELK4 and ELK1 [43]. GABPA, another ETS-domain
transcription factor, has been reported to show a substan-
tial overlap in promoter occupancy with ELK1 and ELK4
[44]. The association of ELK4 with both NFYA and
GABPA motifs suggests that, besides SRF, these factors
could be new partners of ELK4 in macrophages and
should be experimentally validated in future work.Classification of SRF peaks with respect to the loca-
tions of genes revealed that a large fraction of SRF peaks
were located in intergenic regions (37.1%) and introns
(32.4%). Approximately 27.4% of the peaks were located
in the vicinity of promoters (+/− 1000 bp of a transcrip-
tion start site) and only 3.0% in exons (Figure 4C). This
distribution pattern is consistent with our previous SRF
ChIP-seq studies in quiescent primary macrophages [26].
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(923 peaks, 73.1% of the total SRF bound peaks) were also
identified in my SRF ChIP-seq in BLRP-MKL1-BirA cells.
Genomic annotation of MKL1 binding sites indicated a
distribution pattern similar to SRF peaks. 39.7% of the
MKL1 peaks were located in intergenic regions, 30.5% in
introns, 26.8% in promoters and a very small fraction in
exons (3.0%) (Figure 4C). However, the genomic distribu-
tion of ELK4 binding sites differed significantly from that
of SRF and MKL1. Approximately 42.4% of the ELK4
peaks were located in promoters, 32.1% in intergenic re-
gions, 21.2% in introns and a very small fraction in exons
(4.4%) (Figure 4C). This data indicates that ELK4, unlike
SRF and MKL1, may function primarily through promoter-
proximal regions.
The fact that there is a difference in the number of
SRF ChIP-seq peaks in intergenic regions versus those of
ELK4, indicates that SRF participates in some unique
transcription regulation mechanisms independent of its
well-known cofactor, ELK4. There are two possible expla-
nations for this phenomenon. First, SRF could function at
distal enhancers for its regulated genes. This possibility
was verified by our previous study showing that SRF binds
together with PU.1 at distal sites to regulate cell-type spe-
cific cytoskeletal genes using an enhancer-based strategy
[26]. Second, since many non-coding RNAs (ncRNAs) are
found in intergenic regions, it is possible that SRF regu-
lates the expression of ncRNAs. To test this notion, I
examined if there are annotated ncRNA loci within
20 kb of the 1827 SRF intergenic binding sites. My in silico
analysis showed that a significant portion (10.89%) of the
intergenic peaks were associated with annotated ncRNAs
(Figure 4D). A total of 316 unique ncRNAs (Additional
file 11: Table S8) were associated with intergenic SRF peaks,
indicating the possibility of regulation of these ncRNAs by
SRF. A majority of the ncRNAs (84.49%, 267) identified are
classified as long non-coding RNAs (lncRNAs), while 44
are miRNAs (Figure 4E). In support of the possibility of
SRF regulation of ncRNAs, the previously reported SRF tar-
get miRNAs, miR-1 and miR-133, were on the miRNA list
generated by my in silico analysis.
UCSC Genome Browser images of SRF binding to 4 of
its target genes (Srf, Vcl, c-fos and Egr1) are shown in
Figure 5A. Three representative MKL1 peaks associated
with Srf, Vcl and Cyr61 are shown in Figure 5B. Three
representative ELK4 peaks on Srf, c-fos and Egr1 are shown
in Figure 5C.
MKL1 and ELK4 are dedicated to different transcription
programs in macrophages
To check the functional significance of DNA binding of
SRF, MKL1 and ELK4, I used the functional annotation
tool, DAVID, to assess genes associated with binding peaks
of SRF, MKL1 and ELK4, respectively. The top 5 mostrelevant GO terms of biological process for each target
gene list are presented in Figure 6A (full results in
Additional file 12: Table S9, Parts I, II and III). SRF associ-
ated genes were overrepresented with GO terms of “actin
cytoskeleton organization” and “gene expression”. The GO
term “actin cytoskeleton organization” was also selectively
enriched in MKL1 associated genes. In contrast, “gene ex-
pression” appeared as one of the most highly enriched
terms for ELK4 associated genes.
By using KEGG pathway analysis for the SRF, MKL1,
and ELK4 bound genes, I found that MKL1 and ELK4
associated genes contribute to different pathways related
to SRF. For example, SRF and MKL1 associated genes
showed overlapping and enriched pathways of “focal adhe-
sion” and “adherens junction”. In contrast, SRF associated
genes were enriched in the “MAPK signaling pathway”
with ELK4 associated genes. The KEGG term of “path-
ways in cancer” was commonly seen in the analysis of all
of the 3 groups of target genes (Figure 6B, full results in
Additional file 13: Table S10, Parts I, II and III). These
functional differences can be illustrated by different target
genes regulated by the two different cofactors. Actb is an
example of a “focal adhesion” KEGG pathway molecule
and Egr1 is a representative “MAPK signaling pathway”
molecule. Each of these genes are independently regulated
by MKL1 and ELK4 as indicated by genome browser im-
ages. As shown in Figure 6C, Actb is an MKL1-dependent
and ELK4-independent SRF target gene. In contrast, Egr1
is bound by ELK4 and SRF, but not MKL1.
I further confirmed the occupancy of MKL1 and ELK4
on different target genes by ChIP-qPCR and also com-
pared the dynamic binding of MKL1 and ELK4 before
and after zymosan treatment. My experiments confirmed
the abundant enrichment of MKL1 on the promoters of
Srf and Vcl. The observed enrichments were high under
basal conditions and were further enhanced after zymo-
san treatment (Figure 7A). This was in accordance with
the increased expression of MKL1 in response to zymo-
san treatment in the BLRP-MKL1-BirA cell line. Con-
ventional ChIP analysis using primers flanking the peaks
also confirmed ELK4 binding to the promoters of c-fos
and Egr1 (Figure 7B). Although the mRNA expressions
of these two target genes can be highly induced by zy-
mosan treatment, ELK4 occupancy levels remained con-
stant on these two promoters.
Discussion
In this study, I analyzed the role of SRF, and representa-
tive members of its cofactor families in macrophages, in
the context of zymosan stimulation. Using a knockdown
strategy coupled with gene expression array analysis, I
identified target genes whose expressions were dependent
on the intact expression of SRF, MKL1/2 and ELK4,
respectively. Chromatin immunoprecipitation combined
Figure 5 UCSC Genome Browser images for SRF, MKL1 and ELK4 ChIP-seq peaks on representative target genes. (A) UCSC Genome
Browser image of SRF ChIP-seq data at the promoters of Srf, Vcl, c-fos and Egr1, as indicated. (B) UCSC Genome Browser image of MKL1 ChIP-seq
data at the promoters of Srf, Vcl and Cyr61, as indicated. (C) UCSC Genome Browser image of ELK4 ChIP-seq data at the promoters of Srf, c-fos
and Egr1, as indicated.
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Figure 6 MKL1 and ELK4 contribute to distinct programs in SRF mediated transcription regulation. (A) Gene ontology analysis for
biological process annotations of SRF, MKL1 and ELK4 peak associated genes, as indicated. (B) KEGG pathway annotations for SRF, MKL1 and ELK4
peak associated genes, as indicated. (C) UCSC Genome Browser images of SRF, MKL1 and ELK4 ChIP-seq peaks found near the Egr1 and Actb
genes, as indicated.
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tion of direct target genes of SRF, MKL1 and ELK4. Taken
together, my results indicate that MKL1 and ELK4 contri-
bute to distinct aspects of SRF functions in macrophages.
Here, I show that SRF mediates a response to zymosan
stimulation in primary macrophages. The transcription
of Srf was increased by zymosan treatment in an early
phase, similar to other highly characterized immediate
early genes in the literature such as c-fos and Jun. Identi-
fication of the SRF binding element, the CArG box, as
one of the most highly enriched motifs in the promoters
of zymosan induced genes suggests that SRF may play
important roles in zymosan responses in macrophages.Using knockdown analysis combined with gene profiling,
I identified different target gene sets for SRF and mem-
bers of two well-known families of SRF accessory cofac-
tors: the myocardin family members, MKL1/2, and the
TCF family member, ELK4. With regard to the effects of
knocking down SRF, I found that different gene sets with
macrophage specific functions were targets of SRF, includ-
ing genes related to migration, phagocytosis, adhesion and
responses to stimuli. In agreement with previous studies
performed in other cell types, MKL1/2 regulates the
expression of many genes related to actin cytoskeleton
organization in macrophages. These genes showed high
basal expression and little to no induction in response to
Figure 7 Validation of MKL1 and ELK4 recruitment to target gene promoters following zymosan treatment. (A) MKL1 ChIP assay was
performed in BLRP-MKL1-BirA stable cells under basal conditions and after zymosan treatment for 1 h. Immunoprecipitated DNA was analyzed by
Q-PCR using primers flanking the proximal promoter regions of Srf and Vcl. (B) Conventional ELK4 ChIP assay was performed in BLRP-MKL1-BirA
stable cells under basal conditions and after zymosan treatment for 1 h. Rabbit IgG was used as a negative control. Immunoprecipitated DNA was
analyzed by qPCR using primers flanking the proximal promoter regions of c-fos and Egr1.
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genes are overrepresented in the GO term of “response to
stress”. I validated some representative ELK4 target genes
and found that the expressions of these genes were highly
induced by zymosan treatment and that their inductions
were heavily dependent on intact ELK4 expression. Taken
together, it’s proposed that MKL1/2 and ELK4 contribute
to different functions in the quiescent state compared to
the context of an inflammatory response. Moreover, the
microarray data revealed that both MKL1/2 and ELK4 have
some SRF independent functions and that these functions
may involve other novel cofactors.
One of the limitations of microarray analysis is that it
is difficult to differentiate the direct target genes from
the secondary ones. For example, Srf expression itself
can be affected by knocking down MKL1/2 or ELK4. I
also noticed that some ELK4 dependent target genes
showed decreased expression with MKL1/2 loss, which
is probably a secondary effect of SRF expression down-
regulation. Therefore, I performed ChIP-seq analysis to
further identify direct target genes of SRF and its cofac-
tors and to explore novel partners of the three transcrip-
tion factors.
Motif analysis of the SRF bound peaks identified in my
ChIP-seq experiment revealed a set of transcription fac-
tors that could be cofactors of SRF besides ELK4. Someof these factors have already been reported as cofactors of
SRF. For example, SRF acts in conjunction with TEAD1
for cardiac muscle gene regulation [38,42], the interaction
of SRF and NFYA has been verified in vitro [39], and the
interaction of SRF and NFκB has been observed on the
IL-2R enhancer in T lymphocytes [40]. In addition, the
NFκB subunit, p65 (also known as RELA), synergizes with
SRF to activate an SRE containing reporter [41]. My study
also revealed several additional potential cofactors of SRF,
including GABPA, Staf, CREB1, STAT1 and RREB1. An
independent ChIP-seq study in Jurkat T cells found that a
large fraction of SRF peaks occur within 100 bp of GABP
peaks, suggesting that SRF may interact physically with
GABP [45]. Although CREB has not been reported as
directly interacting with SRF, CREB binding protein
(CBP) has been found constitutively bound to the SRE
on the c-fos promoter [46]. RREB1 and SRF were also
both predicted to interact with the same factor, MEF2
[43]. These references provide some evidence for my hy-
pothesis that SRF may interact with cofactors outside of
the myocardin and TCF families.
Our previous ChIP-seq study of SRF in primary mac-
rophages indicated a critical role of SRF in promoting
hematopoietic-cell-restricted gene expression through bind-
ing at distal enhancers, while modulation of generally ex-
pressed genes occurred at promoters [26]. A large fraction
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showed up in my ChIP-seq experiment in the BLRP-
MKL1-BirA cells. Moreover, I also found that SRF-binding
sites are not restricted to promoter regions, but are prefer-
entially located in intergenic regions of the mouse genome.
Through mapping of the intergenic peaks to the mouse
genome, I found that 10.89% of the peaks were associated
with annotated ncRNAs, of which, lncRNAs constitute the
major fraction. A list of miRNAs were also associated with
intergenic SRF peaks, including the known SRF targets,
miR-1 and miR-133 [33]. While MKL1 has a genomic dis-
tribution pattern similar to SRF, as previously reported [19],
ELK4 showed a relatively larger fraction of occupancy on
promoters. In particular, GABPA and NFYA motifs were
found to be enriched on ELK4 bound gene promoters,
suggesting a possible partnership of the two transcription
factors with ELK4.
In addition to validating the MKL1 and ELK4 binding
sites from my ChIP-seq experiment, I also assessed the
binding of these factors in the context of zymosan stimula-
tion. With regard to mRNA expression, MKL1 dependent
genes showed high basal expression and little to no induc-
tion in response to zymosan treatment. By ChIP-qPCR, I
found that MKL1 binding to the promoters of its target
genes was increased after zymosan treatment. Considering
the higher expression of MKL1 after zymosan treatment in
the BLRP-MKL1-BirA stable cells, this enhanced occu-
pancy may reflect an increased expression of BLRP-MKL1
protein. In contrast, ELK4 target gene mRNA levels can be
highly induced by zymosan treatment. However, in the
basal state, ELK4 is already bound to target genes poised
for zymosan induction. I speculate that additional events,
such as post-translational modification of the SRF-cofactor
complex, occur upon zymosan treatment to promote the
function of ELK4-SRF at these loci. Kasza, et al. reported
similar results in which ELK1 and SRF were both found on
the ZC3H12A promoter and that their binding was also
not increased upon IL-1β stimulation [47]. These results
indicate that transcription factor recruitment may not be a
key regulatory event in response to inflammatory stimuli.
Conclusions
In summary, this is the first study to examine the func-
tions of SRF and its key cofactors simultaneously on a
genome-wide level through both ChIP-sequencing and
transcriptome analysis. The overall view of the genome-
wide locations of SRF, MKL1 and ELK4 has been con-
structed and the results suggest that SRF utilizes MKL1
to fulfill steady state cellular functions, including cyto-
skeletal organization, and utilizes ELK4 to facilitate acute
responses to external infection. Previous studies of SRF
largely focused on skeletal, cardiac and smooth muscle
cells and neurons. This project sheds light on the func-
tions of SRF, MKL1 and ELK4 in macrophages, indicatingtheir potential roles for both cellular homeostasis and
stress responses in immune cells.
Methods
Cell culture and transient transfection
Thioglycollate (BD biosciences) -elicited, peritoneal mac-
rophages were prepared as previously described [48] from
6–8 week old, male, C57BL/6 mice (Harlan). For RNAi
experiments, 0.75 million primary macrophages were
transfected with nonspecific (NS) control or SMART-
pool siRNAs (100 nM, Dharmacon) directed against Srf,
Mkl1, Mkl2 and Elk4 using the Deliver X transfection
reagent (Panomics) according to the manufacturer’s in-
structions. RAW 264.7 were transiently transfected with
a 3xCArG luciferase reporter using Superfect reagent
(Qiagen) and luciferase activities were measured using
the luciferase assay system (Promega). Cells were treated
with or without zymosan A (1 mg/mL, Sigma-Aldrich) as
stated in each experiment.
Generation of BLRP-MKL1-BirA cell lines
To achieve rapid and high affinity purification of MKL1
for ChIP-sequencing assay, I generated a BLRP (biotin
ligase recognition peptide)-TEV-Flag-MKL1 expression
vector containing a puromycin resistance gene. BLRP is
a high affinity substrate for the E. coli biotin ligase, BirA,
which biotinylates a lysine residue within the peptide
[49,50]. A RAW264.7 cell line that stably expresses BirA
under neomycin selection has been previously described
[49]. The BLRP-MKL1 expression vector was trans-
fected into the BirA expressing RAW264.7 stable cell
line and stable clones expressing both BirA and BLRP-
tagged MKL1 were identified by puromycin and neomy-
cin double selection.
RNA isolation and Q-PCR
Total RNA (isolated by RNeasy kit, Qiagen) was pre-
pared from untreated or zymosan treated primary mac-
rophages and digested with DNase I according to the
manufacturer's instructions. cDNA was synthesized from
1 μg of total RNA using Superscript III (Invitrogen) reverse
transcriptase according to the manufacturer's instructions.
Quantitative real-time PCR (Q-PCR) analysis was per-
formed using 1 μl of cDNA template, 50 ng of each gene-
specific primer, and SYBR greenER master mix (Invitrogen)
on a 7300 real-time PCR system (Applied Biosystems). Pri-
mer sequences are available upon request.
Gene expression profiling
For the Mkl1/2 double knockdown samples, 0.5 μg of puri-
fied RNA per sample was labeled using the LRILAK PLUS,
two color low RNA input Linear Amplification kit and
hybridized to Whole Mouse Genome Microarray 4 × 44 K
60 mer slides (Agilent) according to the manufacturer’s
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Scanner. For Elk4 knockdown samples, 100 ng of purified
RNA per sample was reverse transcribed using M-MLV
(Takara Chemicals) and amplified by an in vitro transcrip-
tion based method. The Cyanine 3 (Cy3) or Cyanine 5
(Cy5) labeled cDNA was hybridized to the CapitalBio
Mouse Genome Oligo Array (CapitalBio) for 16 h at 42°C.
Arrays were scanned with a LuxScan™ 10 K-A confocal
scanner (CapitalBio), and the data were extracted with
GenePix pro4.0 software (Axon Instruments).Gene ontology (GO) analysis and motif analysis
GO analysis was performed using the web-based func
tional-annotation tool, DAVID (http://david.abcc.ncifcrf.
gov/home.jsp). Gene ontology terms were considered
significant if they had a p-value of less than 0.05. The
oPOSSUM human/mouse single site analysis tool (http://
www.cisreg.ca/oPOSSUM/) was used to identify motifs of
12-bps in length that were overrepresented in different
groups of target sequences [51]. Motifs with a Z-score of
more than 5 and a Fisher Score of less than 0.05 were
regarded as significantly enriched. Terms presented here
are sorted by their respective Fisher scores. Analysis of
the overrepresented miRNAs upstream of target genes
was performed using Ingenuity Pathway Analysis (Ingenuity
Systems, http://www.ingenuity.com).Chromatin immunoprecipitation (ChIP) assay
ChIP assays against MKL1 were performed using the
BLRP-MKL1-BirA cell line with methods similar to those
previously described in [50]. Briefly, cells were crosslinked
with formaldehyde then chromatin was fragmented into
200–300 bp pieces by sonication and subjected to high af-
finity purification with Dynabeads® MyOne™ Streptavidin
T1 (Life technologies). The beads were subjected to
AcTEV Protease (Life Technologies) digestion to release
the tagged MKL1 proteins complexed with interacting
genomic DNA, leaving non-specific proteins bound to
the beads. The MKL1-DNA elution without TEV diges-
tion was used as a background control. Elutions from
TEV digestion were reverse-crosslinked by heating, and
DNA was recovered and purified.
ChIP assays against SRF and ELK4 were performed in
the BLRP-MKL1-BirA cell line with methods similar to
those previously described in [26]. Immunoprecipitations
were performed by incubating with 2.5 μg of anti-SRF
antibody (sc-335, Santa Cruz Biotechnology) or anti-ELK4
antibody (sc-13030, Santa Cruz Biotechnology) overnight
at 4°C. Protein-DNA complexes were recovered using
50 μl of blocked ImmunoPure Protein A Agarose (Pierce)
and then washed, eluted, digested and purified. Rabbit
preimmune serum was used as a control for non-specific
binding.High-throughput ChIP sequencing (ChIP-seq) and
data analysis
Purified ChIP DNA was adapter ligated and PCR amplified
according to the manufacturer’s instructions (Illumina).
High-throughput sequencing was performed on an Illu-
mina Genome Analyzer and short reads (first 23 to 25 bp)
were mapped to the mouse reference genome. Tag counts
for each experiment were normalized to 107 specifically
mapped tags. Sequences with tag counts of more than 20
were regarded as binding peaks. To determine SRF peaks,
SRF ChIP-seq data was compared to a background data set
where SRF ChIP-seq was performed in SRF knockout pri-
mary macrophages. Only those peaks with tag counts at
least 4-fold more than the tag counts in SRF knockout cells
were considered specific. Peaks were visualized by pre-
paring custom tracks using the UCSC Genome Brower
(http://www.genome.ucsc.edu/) based on the protocol
previously described [26]. Peaks were assigned to specific
genes by proximity to the nearest transcription start site.
To search for associated ncRNAs, sequences +/−20 kb
away from target peaks were extracted and mapped to an-
notated ncRNAs based on UCSC mm9 and NCBI build37.
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